---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051835"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:59:23.690974+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech officers Equels and Rodino voluntarily forego 2024 cash bonuses to fund Ampligen R&D

## Summary
- CEO Thomas K. Equels and Peter W. Rodino III notified the Compensation Committee they will forgo their 2024 cash bonuses.
- The voluntary waiver is intended to help AIM focus financial resources on Ampligen R&D activities.
- The Compensation Committee then determined that neither will receive a cash bonus for 2024.

## SEC filing metadata
- accession: 0001493152-24-051835
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315224051835/0001493152-24-051835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315224051835/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051835
- JSON: https://secwatch.observer/filing/0001493152-24-051835.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051835.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.